ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

Human Protein Index Stirs NCI, NCAB Interest, Fires Up Growing Controversy

August 7, 1981

Univ. Of Alabama Resident to Be New HEW Secretary

June 20, 1975

Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees

March 24, 1978

Sen. Arlen Specter Remembered as Champion Of Federal Biomedical Resesarch Funding

October 19, 2012

NCI Bypass Budget Seeks $1 Billion Increase For FY 2011

February 26, 2010